October 9, 2023
New Safety Data Suggests Esketamine Nasal Spray Spravato is more tolerable and effective compared to Quetiapine Extended-Release (XR) in adults with treatment-resistant major depressive disorder
The new safety data is from the ESCAPE-TRD Phase 3b study, which showed esketamine NS demonstrated a significant increase in…
